Is Waiting Longer for New Prescription Drug Approvals Necessarily a Bad Thing?

 Why Canada’s ‘slow and low’ approach to new pharmaceuticals may be the prudent approach. The newest report from Canada’s brand name drug makers on access to new drugs has one key message: compared to other countries, Canada goes slow and low.  New drugs are slower to be covered by our

Canadian Pharmaceutical Companies Take Innovative Approach in Response to United Nations Report to Stop AIDS in Africa

 The United Nations says that access to medicine could save 10 million lives a year globally and is recommending that drug makers support research for neglected diseases and cut prices for medicines in poorer countries. Paul Hunt, an independent UN expert on the right to health, estimates that two billion